Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS

@-Health Unveils the Future of e-Health at CES 2018


AIX-EN-PROVENCE, France, December 7, 2017 /PRNewswire/ --

@-Health, a company specializing in e-cardiology, will be participating for the first time at the CES (Consumer Electric Show), the unmissable event of the world's high-tech, to be held from January 9-12, 2018 in Las Vegas. With the support of French Tech Aix-Marseille, the Aix-based company will present CardioNexion, the first connected medical device for the ultra-early detection and analysis, in real time and continuously, of all cardiovascular pathologies.

     (Logo: http://mma.prnewswire.com/media/617024/Health_Logo.jpg )

Cardiovascular disease is the leading cause of death worldwide according to WHO. In the face of this global public health challenge, @ -Health is setting its sights on being a leading player. By participating in CES 2018, the company intends to demonstrate the relevance of CardioNexion to US investors and find potential partners.

Recall that CardioNexion is a connected medical device that continuously monitors real-time cardiac activity by specialists in cardiology.

It can detect and prevent with certainty any pathology whose first sign is a change in heart rate: stroke, atrial fibrillation, heart failure, sudden infant death, influenza... well before the first symptoms appear.

CardioNexion is also a new tool for practitioners. Indeed, it allows the attending physician to prescribe appropriate treatment and control its effectiveness in real time: a world first!

Specifically, for the patient, the device is in the form of a T-shirt or bra with smart sensors that monitor in real time 24/24 - 365 / day / year many essential data for its health.

This totally ambulatory, non-invasive and autonomous device allows to have the same medical supervision as in an intensive care unit. Via the patient's smartphone, anonymized data, collected 24 hours a day, are sent to secure servers, where they will be analyzed using a proprietary algorithm. They are then transported to a surveillance platform where a team of cardiologists and intensive care unit nurses are ready to respond. If a problem is detected, the patient's doctor is notified. In the most serious cases, "911" is directly called.

FOR MORE INFORMATION

SOURCE @-Health


These press releases may also interest you

at 22:35
Global Times: Xi's fruitful Europe visit brings new impetus to ties
President Xi Jinping left Budapest on Friday, wrapping up his fruitful three-nation Europe visit, which both Chinese and European analysts believe injects momentum into China-Europe relations as well as future multipolarity and global stability. At...

at 20:50
Overture Launches Inner Circles: Redefining Private Attorney Referral Networks
Overture.law, the nation's leading attorney-to-attorney referral platform, launches their transformative new product, Inner Circles. This groundbreaking product empowers attorneys, law schools, bar associations, and affinity groups to build private...

at 20:09
Not Just 1, But 2: BASIS Charter Schools Celebrates a Pair of Students Named Presidential Scholars by the U.S. Department of Education
BASIS Charter Schools proudly announce that two of its exceptional students have been named 2024 U.S. Presidential Scholars by the U.S. Department of Education. Matteo N. Huish from BASIS Mesa and Sruti Peddi from BASIS Scottsdale have been...

at 20:00
Greenberg Traurigs Kemal Hawa to Moderate Panel at DICE East 2024
Kemal Hawa, co-chair of the Digital Infrastructure, Data Center and Cloud Computing Practice of global law firm Greenberg Traurig, LLP, will moderate a panel at DICE East 2024 May 22 in Reston, Virginia. Hawa, a member of the firm's Washington,...

at 19:45
WIO Taps Gracenote to Revolutionize Television Broadcast Reporting
WIO LLC, parent company of the global TV broadcast airings platform, WIOprotm, has announced a new strategic agreement with Gracenote, the global content data business unit of Nielsen, to address the longstanding challenge of accurately tracking and...

at 19:35
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

More news about Science and technology...


News published on and distributed by: